Particularly, it was shown that nicotinamide N-methyltransferase (NNMT) is preferentially expressed in glioma stem cells; NNMT depletes 5-adenosyl-methionine (SAM), a methyl donor generated from methionine. This evidence concerns the gene NNMT and central nervous system cancer.